Circulating cell-free DNA is the biological matrix making it possible to use our technological platform able to screen an organ degradation during a pathological process such as a transplanted kidney or lung during a rejection.

Underused in our field, cell-free DNA and particularly circulating tumoral DNA (ctDNA) has prove its potential for clinical applications such as diagnosis, prognosis and treatment monitoring for cancers patients.